**Core Concept**
The question is testing the concept of anticoagulants and their mechanism of action, specifically in a living organism (in vivo). Anticoagulants are a class of medications used to prevent or treat thrombosis by inhibiting the coagulation cascade.

**Why the Correct Answer is Right**
In vivo, anticoagulants such as heparin, warfarin, and direct oral anticoagulants (DOACs) work by interacting with various components of the coagulation pathway. For example, heparin binds to antithrombin III, enhancing its ability to inactivate thrombin and factor Xa. Warfarin inhibits the synthesis of vitamin K-dependent clotting factors, including prothrombin and factors II, VII, IX, and X. DOACs, such as rivaroxaban and apixaban, directly inhibit factor Xa or thrombin. These mechanisms are specific to living organisms and are not effective in vitro.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a particular anticoagulant mechanism or in vivo context.
**Option B:** This option is incorrect because anticoagulants can be effective in vitro, particularly in laboratory settings where coagulation can be studied and manipulated.
**Option C:** This option is incorrect because while anticoagulants can interact with various components of the coagulation pathway, this statement is too general and does not address the in vivo context.

**Clinical Pearl / High-Yield Fact**
When choosing an anticoagulant, it's essential to consider the specific indication, patient factors, and potential interactions with other medications. For example, warfarin is often used for patients with atrial fibrillation, while DOACs are preferred for patients with acute coronary syndromes.

**Correct Answer: A. Heparin**